Clinical trials
Phase 2 Hyperandrogenism trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Milton S. Hershey Medical Center | 1 |
| National Institutes of Health Clinical Center (CC) | 1 |
| Novartis Pharmaceuticals | 1 |
| University of California, Los Angeles | 1 |
| University of Illinois at Chicago | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperandrogenism | 5 |
| Polycystic Ovary Syndrome | 4 |
| Anovulation | 3 |
| Insulin Resistance | 3 |
| Adrenal Hyperplasia, Congenital | 1 |
| Adrenal Insufficiency | 1 |
| Amenorrhea | 1 |
| Glucose Intolerance | 1 |
| Hirsutism | 1 |
| Inflammation | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.